RT @EpiVax: 300 million patients around the world suffer from a #RareDisease. Getting a diagnosis is difficult for patients, and rarity…
390 followers
417 followers
300 million patients around the world suffer from a #RareDisease. Getting a diagnosis is difficult for patients, and rarity impacts the quality of treatment. EpiVax just published on personalized #immunogenicity risk assessment for #Pompe disease: htt
1,026 followers
RT @FrontImmunol: New Research: Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease: Infantile-onset Pompe d…
33,273 followers
New Research: Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease: Infantile-onset Pompe disease (IOPD) is a glycogen storage disease caused by a deficiency of acid alpha-glucosidase (GAA). Treatment with… https://t.co/YziFZw